Number of the records: 1
Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells
- 1.
SYSNO ASEP 0340647 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells Author(s) Jendželovský, R. (SK)
Mikeš, J. (SK)
Koval, J. (SK)
Souček, Karel (BFU-R) RID, ORCID
Procházková, Jiřina (BFU-R) RID, ORCID
Kello, M. (SK)
Sačková, V. (SK)
Hofmanová, Jiřina (BFU-R) RID, ORCID
Kozubík, Alois (BFU-R) RID, ORCID
Fedoročko, P. (SK)Number of authors 10 Source Title Photochemical & Photobiological Sciences - ISSN 1474-905X
Roč. 8, č. 12 (2009), s. 1716-1723Number of pages 8 s. Language eng - English Country GB - United Kingdom Keywords hypericin ; photodynamic therapy ; ABC transporters Subject RIV BO - Biophysics CEZ AV0Z50040507 - BFU-R (2005-2011) AV0Z50040702 - BFU-R (2007-2013) UT WOS 000272142300010 DOI 10.1039/b9pp00086k Annotation We have investigated the efficiency of a combined modality approach employing 24 h pretreatment of relatively PDT-resistant HT-29 colon adenocarcinoma cells with proadifen followed by HY-PDT. Since significant accumulation of hypericin was found to be a principal factor responsible for ROS induction and therefore higher efficiency of HY-PDT, involvement of ABC transporter system was evaluated. Workplace Institute of Biophysics Contact Jana Poláková, polakova@ibp.cz, Tel.: 541 517 244 Year of Publishing 2010
Number of the records: 1